Non Animal Testing Database

Personalized therapeutic strategies for multiple myeloma

ETH Zurich, Zurich, Switzerland
Despite a growing arsenal of approved therapies, multiple myeloma remains incurable and in need of guidelines to identify effective personalized treatments. In this study, ex vivo drug and immunotherapy sensitivities were surveyed across 101 bone marrow samples derived from 70 patients with multiple myeloma. Multiplexed immunofluorescence, automated microscopy and deep-learning-based single-cell investigation were used. To identify the molecular basis associated with differential drug responses, the drug responses were correlated with myeloma protein abundances. Ex vivo drug sensitivity was compared with clinical treatment responses, including to immunotherapy. Taken together, the study provides molecular insights into diverse treatment strategies for patients with multiple myeloma and enables a personalized medication.
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
Berend Snijder
Added on: 05-05-2023
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!